Search

Now showing items 391-399 of 399

Prediction of major adverse cardiac, cerebrovascular events in patients with diabetes after acute coronary syndrome

2020- Baluja, A.; Rodríguez-Mañero, M.; Cordero, A.; Kreidieh, B.; Iglesias-Alvarez, D.; [et al.]

Cost-Effectiveness Analysis of Apixaban Versus Edoxaban in Patients with Atrial Fibrillation for Stroke Prevention

2020- Oyagüez, I.; Suárez, C.; López-Sendón, J. L.; González Juanatey, José Ramón; de Andrés-Nogales, F.; [et al.]

Reducing residual thrombotic risk in patients with peripheral artery disease: impact of the COMPASS trial

2020- Hernández, J. L.; Lozano, F. S.; Riambau, V.; Almendro-Delia, M.; Cosín-Sales, J.; [et al.]

Myocardium Metabolism in Physiological and Pathophysiological States: Implications of Epicardial Adipose Tissue and Potential Therapeutic Targets

2020- Gandoy Fieiras, Nerea; González Juanatey, José Ramón; Eiras Penas, Sonia

Radiofrequency ablation of an atypical left accessory pathway from the left coronary cusp

2020- Martínez Sande, Jose Luis; González Melchor, Laila; García Seara, Javier; Rodríguez Mañero, Moises; Fernández López, Jesus Alberto; [et al.]

XPO1 Gene Therapy Attenuates Cardiac Dysfunction in Rats with Chronic Induced Myocardial Infarction

2020- García-Manzanares, M.; Tarazón, E.; Ortega, A.; Gil-Cayuela, C.; Martínez-Dolz, L.; [et al.]

Development and validation of a clinical score to estimate progression to severe or critical state in Covid-19 pneumonia hospitalized patients

2020- Gude Sampedro, Francisco; RIVEIRO BLANCO, VANESSA; Rodríguez Núñez, Nuria; Ricoy Gabaldón, Jorge; Lado-Baleato, Óscar; [et al.]

ATP synthase subunit alpha and LV mass in ischaemic human hearts

2015- Roselló-Lletí, E.; Tarazón, E.; Barderas, M. G.; Ortega, A.; Molina-Navarro, M. M.; [et al.]

Effects of alirocumab on types of myocardial infarction: insights from the ODYSSEY OUTCOMES trial

2019- White, H. D.; Steg, P. G.; Szarek, M.; Bhatt, D. L.; Bittner, V. A.; [et al.]

1
. . .
37
38
39
40